Nathalie Ledee/LinkedIn
Sep 29, 2025, 11:50
Nathalie Ledee Highlights Emerging Insights from ESHRE 2025
Nathalie Ledee, Obstetrician Gynecologist and PhD, CEO at MatriceLab, shared a post on LinkedIn:
“It was a great pleasure to spend a whole day immersed in the exciting world of reproductive immunology at this wonderful, huge ESHRE2025 congress. It became clear that immunosuppressive therapies cannot be prescribed indiscriminately. Precision care requires a diagnosis. Another good news is that the concept that endometrial immune equilibrium may help weak embryos (while not being necessary for top-quality ones) is now emerging. Further studies will reveal more about this crucial issue.”
-
May 6, 2026, 01:35Alison Wright: BSGE 2026 Highlights Leadership Change and Future Vision
-
May 6, 2026, 01:30Short Menstrual Cycles May Signal Early Ovarian Ageing – Fertility Plus
-
May 6, 2026, 01:27Asma Khalil: Maternal Mental Health Remains a Leading Risk
-
May 5, 2026, 16:55Pregnancy Outcomes in a Recurrent Miscarriage Population After Uterine Surgeries – Fertility and Sterility
-
May 5, 2026, 16:43MAGENTA Oocyte Scores, Morphokinetics and Live Birth – Future Fertility
-
May 5, 2026, 16:34Join Us on 16 September to Explore Challenges in Managing a Successful Fertility Service – BFS
-
May 5, 2026, 16:17Mature Oocyte Retrieval Without an Exogenous Trigger During Stimulation – Fertility and Sterility
-
May 5, 2026, 16:08We Are Delighted to Announce that Fertility 2027 Registration Opens soon – Fertility Conferences
-
May 5, 2026, 15:59Lillian’s Story Highlights Urgency of Recognising Postpartum Preeclampsia – Preeclampsia Foundation